Expressions of collagen types I and III, fibronectin, and elastin were significantly inhibited in combined treatment compared to gemcitabine alone or control. In all models, YDC002 significantly inhibited tumor growth compared to control or gemcitabine alone and combined treatment showed synergistic effects. This evidence concerns the gene ELN and neoplasm.